These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1437679)

  • 41. Adverse reactions of intravenous immunoglobulin.
    Al-Wahadneh AM; Khriesat IA; Kuda EH
    Saudi Med J; 2000 Oct; 21(10):953-6. PubMed ID: 11369961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survey of oral hygiene regimens among bone marrow transplant centers.
    Ezzone S; Jolly D; Replogle K; Kapoor N; Tutschka PJ
    Oncol Nurs Forum; 1993 Oct; 20(9):1375-81. PubMed ID: 8265442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy.
    Daphnis E; Stylianou K; Alexandrakis M; Xylouri I; Vardaki E; Stratigis S; Kyriazis J
    Nephron Clin Pract; 2007; 106(4):c143-8. PubMed ID: 17596722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous immunoglobulin treatment in autoimmune neurological disorders--effects on quality of life.
    Padua L; Sabatelli M; Evoli A; Pazzaglia C; Tonali P
    Hum Immunol; 2005 Apr; 66(4):417-21. PubMed ID: 15866706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous immunoglobulin: immune modulatory effects in vitro and clinical effects in allogeneic bone marrow transplant recipients.
    Klaesson S; Ringdén O; Markling L; Tammik L
    Transplant Proc; 1995 Dec; 27(6):3536-7. PubMed ID: 8540089
    [No Abstract]   [Full Text] [Related]  

  • 47. The next step to improving cancer pain management.
    Miaskowski C
    Pain Manag Nurs; 2005 Mar; 6(1):1-2. PubMed ID: 15917738
    [No Abstract]   [Full Text] [Related]  

  • 48. [The initial consultation in geriatric oncology and the key role of the nurse clinician].
    Guérin O; Cammas N; Bereder I
    Soins Gerontol; 2007; (66):30-1. PubMed ID: 17708500
    [No Abstract]   [Full Text] [Related]  

  • 49. Nursing care issues in autologous bone marrow transplantation.
    Whedon M; Damianos FL
    Oncology (Williston Park); 1993 Jun; 7(6):78-88; discussion 91-2, 95. PubMed ID: 8318361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous immunoglobulins-induced eczematous eruption: a long-term follow-up study.
    Cohen Aubart F; Barete S; Amoura Z; Francès C; Lyon-Caen O; Lebrun-Vignes B
    Eur J Intern Med; 2009 Jan; 20(1):70-3. PubMed ID: 19237096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety of liquid intravenous immunoglobulin for neuroimmunologic disorders in the home setting: a retrospective analysis of 1085 infusions.
    Rigas M; Tandan R; Sterling RJ
    J Clin Neuromuscul Dis; 2008 Dec; 10(2):52-5. PubMed ID: 19169090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levels.
    Cottler-Fox M; Lynch M; Pickle LW; Cahill R; Spitzer TR; Deeg HJ
    Bone Marrow Transplant; 1991 Jul; 8(1):27-33. PubMed ID: 1655138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Intravenous administration of immunoglobulin--preparations and theoretical basis of their use].
    Jankowski A
    Postepy Hig Med Dosw; 2002; 56 Suppl():5-12. PubMed ID: 12661409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost of intravenous immunoglobulin therapy versus conventional immunosuppressive therapy in patients with mucous membrane pemphigoid: a preliminary study.
    Daoud Y; Amin KG; Mohan K; Ahmed AR
    Ann Pharmacother; 2005 Dec; 39(12):2003-8. PubMed ID: 16264064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosing graft versus host disease.
    O'Rourke ME; High K
    Clin J Oncol Nurs; 2000; 4(1):47-8. PubMed ID: 10865586
    [No Abstract]   [Full Text] [Related]  

  • 56. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
    Whimbey E; Champlin RE; Englund JA; Mirza NQ; Piedra PA; Goodrich JM; Przepiorka D; Luna MA; Morice RC; Neumann JL
    Bone Marrow Transplant; 1995 Sep; 16(3):393-9. PubMed ID: 8535312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implementation of the American Pain Society Quality Assurance Standards for Relief of Acute Pain and Cancer Pain in oncology nursing practice.
    Miaskowski C; Donovan M
    Oncol Nurs Forum; 1992 Apr; 19(3):411-5. PubMed ID: 1594463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of high-dose human intravenous immunoglobulin therapy in sensitized patients awaiting transplantation: the Cedars-Sinai experience.
    Jordan SC; Vo AA; Nast CC; Tyan D
    Clin Transpl; 2003; ():193-8. PubMed ID: 15387111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A pedagogical contract].
    Remaki N
    Soins Form Pedagog Encadr; 1993; (6):39-41. PubMed ID: 7804539
    [No Abstract]   [Full Text] [Related]  

  • 60. The state of academic science: concern about the vital signs.
    Walsh J
    Science; 1977 Jun; 196(4295):1184-5. PubMed ID: 17787078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.